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cases with this procedure, we wonder
whether the results have always been good.
Although we have some points to be
clarified, we again congratulate Fukuda
and associates1 on their successful results
in this complicated case. In our opinion,
transapical aortic cannulation should be the
last alternative. No one can predict the re-
sults of this procedure.
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Reply to the Editor:
We thank Terada and Nakamura for their
comments regarding our work.1 Transapical
aortic cannulation was originally described in
the 1970s. However, it has been unpopular
because of similar comments by the critics.
Originally this method was used in sur-
gery for congenital heart disease or mitral
valvular disease.2 The main reason for the
use of transapical aortic cannulation today
is for surgery on diseased aorta without
intracardiac abnormality. Thus the indica-
tion for this method today is different from
that during the 1970s.
We have used transapical aortic cannu-
lation in 4 patients (2 in median sternotomy
and 2 in left thoracotomy) without any se-
rious adverse effects. Although the volume
of our experience is small, we would like to
comment on it. With respect to hypoten-
sion during elevation of the apex, its dura-
tion was quite short, and the blood pressure
recovered as soon as the apex was lowered
into normal position. Although elevation of
the apex of a beating heart can be an un-
comfortable procedure for a cardiac sur-
geon, we were accustomed to this proce-
dure from our recent experience with off-
pump coronary artery bypass grafting.
In addition, hypotension during insertion
of the cannula was advantageous to reduce
the amount of bleeding during puncture of
the apex. To prevent devastating hemorrhage
during cannulation and to avoid dislocation
of the cannula, purse-string suture with Da-
cron polyester felt was placed at the apex and
preliminary venous cannulation was per-
formed. In 2 patients the femoral artery was
cannulated as an accessory perfusion site to
the lower extremities. We evaluated aortic
regurgitation during aortic perfusion, and it
was mild on duplex scanning. Intraoperative
findings revealed a competent aortic valve
with aortic cannula positioning at the center
of the aortic orifice. Although clamping of
the ascending aorta was impossible, all 4
patients underwent replacement of the aortic
arch under deep hypothermic circulatory ar-
rest either with or without selective cerebral
perfusion, depending on the needs of each
case.
Administration of cardioplegic solution
was thus performed after the aorta was
transected under deep hypothermic arrest.
Therefore inability to administer cardiople-
gic solution was not an essential problem.
Repair of the apex was completed during
cardiac arrest, and systemic perfusion was
resumed through cannula in the graft.
We concur with Terada and Nakamura
regarding the usefulness of the axillary artery
as the first alternative access to the femoral
artery.3 We used axillary artery cannulation
in 23 of 935 patients who underwent cardiac
surgery with cardiopulmonary bypass. In the
4 patients who underwent transapical cannu-
lation, both the femoral artery and axillary
artery were inaccessible or inadequate as a
systemic perfusion site because of com-
pressed true lumen of the descending aorta,
severe obesity, or subclavian artery disease.
If a patient has these conditions, transapical
aortic cannulation is indicated. We believe
that transapical aortic cannulation is safe and
useful for such selected patients.
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Thymectomy in ocular myasthenia
gravis
To the Editor:
We read with interest the recent article by
Roberts and associates1 on thymectomy in
the treatment of ocular myasthenia gravis
(OMG). It represents an important step in
the debate concerning this issue and in the
consideration of OMG as part of a broad-
spectrum disease and not as a distinct dis-
ease.
What we know from the literature is
that the disease will progress in about 50%
of patients with initial OMG.2 On the other
hand, thymectomy is considered a main-
stay therapy for generalized myasthenia
gravis (GMG), and the best outcome is
expected in patients operated on early after
the onset of the disease.
What we should simply do is predict
when a pure OMG is an initial GMG and
offer to such patients the best treatment,
which might also include an extended
thymectomy.
Apart from the presence of a thymoma,
which makes the surgical procedure man-
datory, no clear indication for thymectomy
in OMG appears in the literature.
Only a few studies have focused on
thymectomy in OMG,1,3-5 and when pa-
tients with OMG are merged with those
with GMG, the assessment of the efficacy
of thymectomy is difficult for the combined
action of various medical therapies and for
the lack of standardized methods for as-
sessing patient status before and after sur-
gical intervention and assessing the correct
criteria of success.
A contribution to the discussion about
this topic might be derived from our expe-
rience.
From 1993 to now, 29 patients with
OMG underwent transternal extended
thymectomy at our institution. In the same
period, the same neurologist (R.R.) treated
343 patients with OMG, and consequently,
the eligibility rate for surgical treatment of
OMG was 8.5%.
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